MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 12-16-2024
Country |
 USA |
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NYSE |
Shares |
50.9 K |
Market Cap[1] |
$ 14.8 K |
EBITDA (LTM) |
$ -16.9 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
-0.32 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Anixa Biosciences
ANIX
|
$ 3.1 | -2.98 % | $ 101 K | Nasdaq Capital Market | USA |
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.44 | -3.93 % | $ 1.83 M | Nasdaq Capital Market,SPB | USA |
 |
Brainsway Ltd.
BWAY
|
$ 22.14 | -4.49 % | $ 99.4 M | Nasdaq Global Select Market |  Israel |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 30.5 | -4.72 % | $ 328 M | Nasdaq Global Market |  China |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Castle Biosciences
CSTL
|
$ 41.02 | 2.52 % | $ 1.14 B | Nasdaq Global Market,SPB | USA |
 |
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | USA |
 |
DexCom
DXCM
|
$ 70.83 | 1.86 % | $ 27.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Guardant Health
GH
|
$ 112.54 | 0.36 % | $ 13.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 20.02 | 0.07 % | $ 1.08 B | Nasdaq Global Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 235.11 | -0.38 % | $ 172 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 106.55 | -0.38 % | $ 4.2 B | Nasdaq Global Select Market | USA |
 |
Illumina
ILMN
|
$ 145.35 | 2.61 % | $ 23.1 B | Nasdaq Global Select Market,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 12.48 | 0.28 % | $ 354 M | Nasdaq Capital Market | Israel |
 |
Fulgent Genetics
FLGT
|
$ 27.76 | -1.14 % | $ 839 M | Nasdaq Global Market | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 102.17 | -0.26 % | $ 18.9 B | Nasdaq Capital Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 66.39 | 3.33 % | $ 4.59 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 234.23 | -1.45 % | $ 42.5 B | NYSE,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 605.53 | -0.88 % | $ 18.7 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.24 | -0.05 % | $ 2 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 22.08 | -0.63 % | $ 542 M | Nasdaq Global Select Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 219.44 | -0.07 % | $ 11.3 B | NYSE,SPB | USA |
 |
OPKO Health
OPK
|
$ 1.28 | 0.12 % | $ 888 M | Nasdaq Global Select Market | USA |
 |
Pacific Biosciences of California
PACB
|
$ 2.34 | 5.88 % | $ 593 M | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 190.16 | 0.34 % | $ 21.1 B | NYSE,SPB | USA |
|
Biodesix
BDSX
|
$ 8.9 | 12.88 % | $ 1.15 B | Nasdaq Global Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 406.29 | -3.72 % | $ 29.8 B | NYSE,SPB |  Schweiz |
 |
Laboratory Corporation of America Holdings
LH
|
$ 274.22 | 1.19 % | $ 23 B | NYSE,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 175.91 | -3.67 % | $ 14.5 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 693.45 | -3.06 % | $ 57.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 5.57 | -5.91 % | $ 505 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.67 | -2.3 % | $ 2.51 M | Nasdaq Global Select Market | USA |
 |
Agilent Technologies
A
|
$ 135.26 | -3.14 % | $ 41.1 B | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.